These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7956939)
1. Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model. Costagliola S; Many MC; Stalmans-Falys M; Tonacchera M; Vassart G; Ludgate M Endocrinology; 1994 Nov; 135(5):2150-9. PubMed ID: 7956939 [TBL] [Abstract][Full Text] [Related]
2. Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice. Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M Endocrinology; 1996 Nov; 137(11):4637-43. PubMed ID: 8895327 [TBL] [Abstract][Full Text] [Related]
3. The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background. Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M Mol Cell Endocrinol; 1995 Dec; 115(2):199-206. PubMed ID: 8824895 [TBL] [Abstract][Full Text] [Related]
4. Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R. Costagliola S; Alcalde L; Tonacchera M; Ruf J; Vassart G; Ludgate M Biochem Biophys Res Commun; 1994 Mar; 199(2):1027-34. PubMed ID: 8135775 [TBL] [Abstract][Full Text] [Related]
5. Development of an animal model of autoimmune thyroid eye disease. Many MC; Costagliola S; Detrait M; Denef F; Vassart G; Ludgate MC J Immunol; 1999 Apr; 162(8):4966-74. PubMed ID: 10202044 [TBL] [Abstract][Full Text] [Related]
6. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. Morgenthaler NG; Ho SC; Minich WB J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882 [TBL] [Abstract][Full Text] [Related]
8. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. Costagliola S; Rodien P; Many MC; Ludgate M; Vassart G J Immunol; 1998 Feb; 160(3):1458-65. PubMed ID: 9570567 [TBL] [Abstract][Full Text] [Related]
9. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564 [TBL] [Abstract][Full Text] [Related]
10. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies. Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437 [TBL] [Abstract][Full Text] [Related]
11. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy. Baker G; Mazziotti G; von Ruhland C; Ludgate M Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454 [TBL] [Abstract][Full Text] [Related]
12. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease. Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516 [TBL] [Abstract][Full Text] [Related]
13. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor. Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861 [TBL] [Abstract][Full Text] [Related]
14. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease. Michelangeli VP; Poon C; Topliss DJ; Colman PG Thyroid; 1995 Jun; 5(3):171-6. PubMed ID: 7580264 [TBL] [Abstract][Full Text] [Related]
15. Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of L-thyroxine therapy. Khoo DH; Eng PH; Ho SC; Fok AC Clin Endocrinol (Oxf); 1999 Jul; 51(1):73-9. PubMed ID: 10468968 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of thyroid blocking antibody (TBAb) on the thyroid stimulatory effect of human chorionic gonadotropin (HCG) and equine chorionic gonadotropin (ECG). Ochi Y; Hamazu M; Kajita Y; Hachiya T; Hamaoki M Endocr J; 2010; 57(4):311-5. PubMed ID: 20351465 [TBL] [Abstract][Full Text] [Related]
17. Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies. Diana T; Wüster C; Kanitz M; Kahaly GJ J Endocrinol Invest; 2016 Oct; 39(10):1159-65. PubMed ID: 27197966 [TBL] [Abstract][Full Text] [Related]
18. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins. Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935 [TBL] [Abstract][Full Text] [Related]
19. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477 [TBL] [Abstract][Full Text] [Related]
20. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination. Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]